Currently there are two preferred brands of rescue inhaler for commercial and Medicare Part D members, including
Effective October 1, 2013, IBC will designate ProAir HFA as our only preferred brand of rescue inhaler for commercial members. Medicare Part D members will not be affected by this change.
Commercial members who are currently prescribed a rescue inhaler were mailed a letter notifying them of this change.
The letter explained that in order for other brands of rescue inhaler to be covered, prior authorization will be required and,
in some cases, members will pay a higher level of cost-sharing.
Prescribing options for commercial members as of October 1, 2013:
- Prescribe ProAir HFA. ProAir HFA will continue to be covered at the brand formulary level of cost-sharing. Prior authorization will not be required.
- Prescribe a non-preferred rescue inhaler (i.e., other than ProAir HFA). You will need to submit to FutureScripts® a prior authorization request using the General Pharmacy form. In some cases, members who are prescribed a non-preferred rescue inhaler will be responsible for the highest
non-formulary level of cost-sharing.
If ProAir HFA is not prescribed, we strongly recommend that you
allow additional time for us to process the prior authorization
request when writing a new prescription.
If you have any questions, please contact FutureScripts at 1-888-678-7012.